Decreased expression of calretinin in the cerebral cortex and hippocampus of SOD1G93A transgenic mice

Brain Research

Volumn 1035, Issue 1, 2005, Pages 105-109

  Chung, Yoon Hee ^a   Joo, Kyeung Min ^b   Nam, Ryoung Hee ^b   Cho, Mi Haeng ^b   Kim, Dae Jin ^a   Lee, Won Bok ^a   Cha, Choong Ik ^b,c  

^a Chung Ang University   (South Korea)

^b Seoul National University   (South Korea)

^c Korea National Institute of Health   (South Korea)

Author keywords

Amyotrophic lateral sclerosis (ALS); Calretinin (CR); Cerebral cortex; Hippocampus; SOD1G93A transgenic mice

Indexed keywords

CALRETININ;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DENTATE GYRUS; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRANSGENIC MOUSE;

EID: 13844264133     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.12.022     Document Type: Article

References (26)

1. A. Al-Chalabi, and P.N. Leigh Recent advances in amyotrophic lateral sclerosis Curr. Opin. Neurol. 13 2000 397 405
2. M.E. Alexianu, B.-K. Ho, A.H. Mohamed, V. La Bella, R.G. Smith, and S.H. Appel The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis Ann. Neurol. 36 1994 846 858
3. M.E. Alexianu, E. Manole, J.I. Engelhardt, and S.H. Appel Ultrastructural evidence of calcium involvement in experimental autoimmune gray matter disease J. Neurosci. Res. 60 2000 98 105
4. K.G. Baimbridge, M.R. Celio, and J.H. Rogers Calcium-binding proteins in the nervous system Trends Neurosci. 15 1992 303 308
5. M.R. Celio Calbindin D-28 k and parvalbumin in the rat nervous system Neuroscience 35 1990 375 475
6. D.W. Choi Excitotoxic cell death J. Neurobiol. 93 1992 1261 1276
7. G93A mutant transgenic mice Brain Res. 994 2003 253 259
8. Y.H. Chung, K.M. Joo, M.J. Kim, and C.I. Cha Immunohistochemical study on the distribution of alpha-synuclein in the central nervous system of transgenic mice expressing a human Cu/Zn superoxide dismutase mutation Neurosci. Lett. 342 2003 151 154
9. Y.H. Chung, J.J. Hong, C.M. Shin, K.M. Joo, M.J. Kim, and C.I. Cha Immunohistochemical study on the distribution of homocysteine in the central nervous system of transgenic mice expressing a human Cu/Zn SOD mutation Brain Res. 967 2003 226 234
10. G93A transgenic mice Brain Res. 1016 2004 272 280
11. J.L. Elliott, and W.D. Snider Parvalbumin is a marker of ALS-resistant motor neurons NeuroReport 6 1995 449 452
12. M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, H.X. Deng, W. Chen, P. Zhai, R.L. Sufit, and T. Siddique Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation Science 264 1994 1772 1775
13. H.A. Hanagasi, I.H. Gurvit, N. Ermutlu, G. Kaptanoglu, S. Karamursel, H.A. Idrisoglu, M. Emre, and T. Demiralp Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials Brain Res. Cogn. Brain Res. 14 2002 234 244
14. C. Krieger, K. Jones, S.U. Kim, and A.A. Eisen The role of intracellular free calcium in motor neuron disease J. Neurol. Sci. 124 1994 27 32
15. C.L. Lin, L.A. Bristol, L. Jin, M. Dykes-Hoberg, T. Crawford, L. Clawson, and J.D. Rothstein Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis Neuron 20 1998 589 602
16. E.A. Nimchinsky, W.G. Young, G. Yeung, R.A. Shah, J.W. Gordon, F.E. Bloom, J.H. Morrison, and P.R. Hof Differential vulnerability of oculomotor, facial, and hypoglossal nuclei in G86R superoxide dismutase transgenic mice J. Comp. Neurol. 416 2000 112 125
17. K.S. Paulus, I. Magnano, M.R. Piras, M.A. Solinas, G. Solinas, G.F. Sau, and I. Aiello Visual and auditory event-related potentials in sporadic amyotrophic lateral sclerosis Clin. Neurophysiol. 113 2002 853 861
18. A.H. Pullen, and P. Humphreys Ultrastructural analysis of spinal motoneurones from mice treated with IgG from ALS patients, healthy individuals, or disease controls J. Neurol. Sci. 180 2000 35 45
19. L.P. Rowl, and N.A. Shneider Amyotrophic lateral sclerosis N. Engl. J. Med. 344 2001 1688 1700
20. D. Seilhean, J. Takahashi, K.H. El Hachimi, H. Fujigasaki, A.S. Lebre, V. Biancalana, A. Durr, F. Salachas, J. Hogenhuis, H. De The, J.J. Hauw, V. Meininger, A. Brice, and C. Duyckaerts Amyotrophic lateral sclerosis with neuronal intranuclear protein inclusions Acta Neuropathol. (Berl). 108 2004 81 87
21. P.J. Shaw, and C.J. Eggett Molecular factors underlying selective vulnerability of motor neurons to neurodegeneration in amyotrophic lateral sclerosis J. Neurol. 247 2000 I17 27
22. L. Siklós, J.I. Engelhardt, M.E. Alexianu, M.E. Gurney, T. Siddique, and S.H. Appel Intracellular calcium parallels motoneuron degeneration in SOD-1 mutant mice J. Neuropathol. Exp. Neurol. 57 1998 571 587
23. L. Siklós, J.I. Engelhardt, R. Adalbert, and S.H. Appel Calcium-containing endosomes at oculomotor terminals in animal models of ALS NeuroReport 10 1999 2539 2545
24. M. Strong, and J. Rosenfeld Amyotrophic lateral sclerosis: a review of current concepts Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4 2003 136 143
25. B.K. Vanselow, and B.U. Keller Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease J. Physiol. 525 2000 433 445
26. O. Yokota, S. Terada, H. Ishizu, T. Ishihara, H. Nakashima, A. Kugo, K. Tsuchiya, K. Ikeda, T. Hayabara, Y. Saito, S. Murayama, K. Ueda, F. Checler, and S. Kuroda Increased expression of neuronal cyclooxygenase-2 in the hippocampus in amyotrophic lateral sclerosis both with and without dementia Acta Neuropathol. (Berl). 107 2004 399 405